Spring 2007 Newsletter
Actively Recruiting Studies
Memory & Cognition
HOPE: Health Outreach Program for the Elderly
This longitudinal study increases our understanding of agerelated changes in memory and thinking. It serves as the BU ADC’s main research registry, where participants agree to be contacted regarding other BU ADC-approved studies.
Understanding False Memory in AD
This study seeks to better understand why patients with Alzheimer’s disease (AD) and other dementias frequently remember things that never happened. The ultimate goal of this NIA-sponsored study is to provide the basis for ways to reduce false memories in patients with dementia.
Caregiving Support & Education
CARE-Plus
This caregiver-based study is seeking to determine whether an educational intervention can reduce behavior problems in patients with AD and improve caregivers’ emotional well-being. It consists of a 5-week group intervention which offers 90-minute weekly sessions on AD, its symptoms, and tips for improving communication and interactions with the family member. It also focuses on family members’ feelings about their own caregiving skills. The individual with AD is not involved in this study.
Genetics
MIRAGE: Multi-Institutional Research in Alzheimer’s Genetic Epidemiology
This longstanding study evaluates the association between genetic (hereditary) and non-genetic risk factors for AD. The study is currently recruiting people with a diagnosis of probable AD who also have an unaffected sibling who would be willing to participate with them. The study is being conducted at multiple sites in the United States and abroad.
REVEAL III: Risk Evaluation and Education for Alzheimer’s Disease
This study is a multi-center, nationwide research project. The goal of REVEAL-III is to provide healthy adults with genetic susceptibility testing and information about their chances to develop AD.
Treatment
DHA (new study)
This new study is a multi-center clinical trial that will evaluate the effectiveness of a new medication, DHA, in slowing the progression of AD. The study is recruiting participants with mild to moderate AD who have a caregiver available to accompany them to clinic visits.
For more information, please call the recruitment coordinator, Erin Whalen, at 617 414-1078
|
